Amy Murphy
Nurse Practitioner · Palo Alto, CANPI 1821430281
Payments from drug & device makers
Across 126 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$611
- Mayne Pharma Commercial LLC$398
- Exeltis, USA Inc.$156
- Therapeuticsmd, Inc.$149
- Bayer$141
- Astellas Pharma US Inc$126
- plus $824 from 23 others
What the payments were for
- Food & beverage$2,38399%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $611 |
| Mayne Pharma Commercial LLC | 14 | $398 |
| Exeltis, USA Inc. | 9 | $156 |
| Therapeuticsmd, Inc. | 8 | $149 |
| Bayer | 8 | $141 |
| Astellas Pharma US Inc | 5 | $126 |
| Organon | 6 | $90 |
| Merck | 4 | $72 |
| Pfizer | 4 | $72 |
| Coopersurgical, Inc. | 4 | $69 |
| Medicem Inc. | 4 | $53 |
| Agile Therapeutics, Inc. | 3 | $47 |
| Myovant Sciences Inc. | 2 | $41 |
| Shield Therapeutics Inc | 2 | $39 |
| Optumhealth Care Solutions, LLC | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Avion Pharmaceuticals | 2 | $29 |
| Axonics, Inc. | 1 | $24 |
| GSK | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Mycovia Pharmaceuticals, Inc. | 1 | $23 |
| Coloplast | 1 | $23 |
| Gynesonics, Inc. | 1 | $21 |
| Aspira Women's Health Inc | 1 | $18 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $14 |
| Exact Sciences | 1 | $13 |
How this compares
$2,406 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 11 | $265 |
| LarinNorethindrone Ac/Eth Estradiol | 12 | $155 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Palo Alto
- Jong Mi LeePalo Alto$174K
- Carol BarchPalo Alto$76K
- Holly BernalPalo Alto$63K
- Lindsay MartinPalo Alto$37K
- Janice LuPalo Alto$27K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.